146 related articles for article (PubMed ID: 37855423)
1. Colorectal Cancer Screening for Persons With a Positive Family History—Evaluation of the FARKOR Program for the Secondary Prevention of Colorectal Cancer in Persons Aged 25 to 50.
Crispin A; Rehms R; Hoffmann S; Lindoerfer D; Hallsson LR; Jahn B; Mühlberger N; Sroczynski G; Siebert U; Mansmann U
Dtsch Arztebl Int; 2023 Nov; 120(46):786-792. PubMed ID: 37855423
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
[TBL] [Abstract][Full Text] [Related]
3. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
6. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
8. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk.
Sroczynski G; Hallsson LR; Mühlberger N; Jahn B; Rehms R; Hoffmann S; Crispin A; Lindoerfer D; Mansmann U; Siebert U
Int J Cancer; 2024 Feb; 154(3):516-529. PubMed ID: 37795630
[TBL] [Abstract][Full Text] [Related]
10. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
[TBL] [Abstract][Full Text] [Related]
11. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
12. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
14. Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.
Hillyer GC; Schmitt KM; Freedberg DE; Kramer RA; Su Y; Rosenberg RM; Neugut AI
Am J Prev Med; 2014 Aug; 47(2):182-7. PubMed ID: 24951037
[TBL] [Abstract][Full Text] [Related]
15. The impact of stratifying by family history in colorectal cancer screening programs.
Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
17. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
[TBL] [Abstract][Full Text] [Related]
19. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
Buchman S; Rozmovits L; Glazier RH
Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
[TBL] [Abstract][Full Text] [Related]
20. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
